The Washington Post, February 26, 2017: A divided White House still offers little guidance on replacing Obamacare
“Where Trump will end up remains unclear, although in both public and private settings he has tended to stress the importance of providing health coverage ‘for everybody’ while lowering its cost. However, Price testified during his recent confirmation hearings that the administration would seek to give Americans access to, not guaranteed, coverage.
The policy proposal Trump has embraced most forcefully, albeit not always consistently, is to pressure pharmaceutical firms to lower their prices by negotiating government drug purchases through Medicare. The idea has considerable support among Democrats and from some Republicans but is currently prohibited under law.”